Cleerly is a pioneering digital healthcare enterprise specializing in addressing heart disease. At its core, Cleerly offers a cutting-edge AI-powered digital care platform designed to collaborate with coronary computed tomography angiography (CCTA) imaging. This innovative platform empowers healthcare professionals to detect and characterize atherosclerosis at an earlier stage, facilitating the creation of tailored treatment strategies. By precisely assessing atherosclerosis, which refers to the accumulation of plaque in the arteries of the heart, Cleerly's platform streamlines the process of evaluating and reporting heart disease, providing a simpler, swifter, and more precise approach. Established in 2017 and headquartered in New York, New York, Cleerly is at the forefront of revolutionizing cardiac care.